Lauren Juneja in Baton Rouge, Louisiana

Home Louisiana Baton Rouge

Lauren Juneja has Hematology/oncology as her primary medical specialty. Their primary office is: 4950 Essen Ln in Baton Rouge, Louisiana.

They're a part of the: Mary Bird Perkins Cancer Center medical group which has around 31 members. You can call their office at 225-767-0847 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Louisiana State University School Of Medicine In Shreveport and graduated in 2012 (around 12 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Lauren E Juneja Office Phone and Directions

Lauren Juneja
Mary Bird Perkins Cancer Center
4950 Essen Ln
Baton Rouge, Louisiana 70809
225-767-0847

Patient Ratings
Please rate your experience with Lauren Juneja below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 225-767-0847

Enter a starting address:

Healthcare Info for Lauren Juneja

Medical School: Louisiana State University School Of Medicine In Shreveport
Graduation Year: 2012
The Primary Medical Specialty for Lauren Juneja is listed as: Hematology/oncology
Approximate Years of Experience: 12
PAC (PECOS ID)#: 0143525030
NPI #: 1205192804
NPI Created On: 04/09/2012
NPI Last Updated Listed as: 07/02/2021
Primary Taxonomy Code: 207RX0202X
License Number:
MD.207928
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of drug or substance into a vein for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
New patient office or other outpatient visit, typically 30 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
Injection, dexamethasone sodium phosphate, 1 mg

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787984375

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787984371

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787984373

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781011493

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781011495

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781011497

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818624275

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: VERZENIO

Associated Drug #2: 0002-6216-54

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818625901

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803161121

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: ZEJULA

Open Associated Drug #1: 69656-103-90

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832188815

Being Disputed:: No

Product Related: No

Hematology/oncology Professionals in Baton Rouge

1.
Sukanthini Subbiah

5825 Airline Hwy
Baton-rouge, LA
Louisiana State University School Of Medicine In New Orleans Faculty G

2.
Caitlin Lopes

17050 Medical Ctr Dr
Baton-rouge, LA
Ochsner Clinic Llc

3.
Gerald Miletello

8585 Picardy Ave
Baton-rouge, LA
American Oncology Partners Pa

4.
Constance Blunt

4950 Essen Ln
Baton-rouge, LA
Mary Bird Perkins Cancer Center

5.
Caitlin Taylor

17050 Medical Ctr Dr
Baton-rouge, LA
Ochsner Clinic Llc

6.
Derrick Spell MD

4950 Essen Ln
Baton-rouge, LA
Mary Bird Perkins Cancer Center

Providers in Mary Bird Perkins Cancer Center

1.Richard Bermudez

1203 S Tyler St
Covington La 70433-2353
Mary Bird Perkins Cancer Center
Radiation Oncology

2.Richard Bermudez

4950 Essen Ln
Baton Rouge La 70809-3738
Mary Bird Perkins Cancer Center
Radiation Oncology

3.Bryan Bienvenu

4950 Essen Ln
Baton Rouge La 70809-3738
Mary Bird Perkins Cancer Center
Hematology/oncology

4.Constance Blunt

4950 Essen Ln
Baton Rouge La 70809-3738
Mary Bird Perkins Cancer Center
Hematology/oncology

5.Andre Bonnecaze

4950 Essen Ln
Baton Rouge La 70809-3738
Mary Bird Perkins Cancer Center
Internal Medicine

6.Kitzia Bordlee

4950 Essen Ln
Baton Rouge La 70809-3738
Mary Bird Perkins Cancer Center
Clinical Social Worker

View all 31 members of Mary Bird Perkins Cancer Center medical group